BeOne Medicines Ltd. (ONC) Earnings History
Annual and quarterly earnings data from 2013 to 2025
Loading earnings history...
ONC EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ONC Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 87.5% | 8.4% | 5.4% |
| 2024 | 84.4% | -14.9% | -16.9% |
| 2023 | 84.5% | -49.1% | -35.9% |
| 2022 | 79.8% | -126.4% | -141.5% |
| 2021 | 86.0% | -122.3% | -123.9% |
Download Data
Export ONC earnings history in CSV or JSON format
Free sign-in required to download data
BeOne Medicines Ltd. (ONC) Earnings Overview
As of May 8, 2026, BeOne Medicines Ltd. (ONC) reported trailing twelve-month net income of $513M, reflecting +637.4% year-over-year growth. The company earned $4.43 per diluted share over the past four quarters, with a net profit margin of 5.4%.
Looking at the long-term picture, ONC's historical earnings data spans multiple years. The company achieved its highest annual net income of $287M in fiscal 2025, representing a new all-time high.
BeOne Medicines Ltd. maintains positive profitability with a gross margin of 87.5%, operating margin of 8.4%, and net margin of 5.4%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including ZYME (-$44.22B net income, -76.6% margin), RCUS (-$369M net income, -142.9% margin), TGTX ($462M net income, 72.6% margin), ONC has outperformed on profitability metrics. Compare ONC vs ZYME →
ONC Earnings vs Peers
Earnings metrics vs comparable public companies
ONC Historical Earnings Data (2013–2025)
13 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $287M | +144.5% | $447M | $32.89 | 5.4% | 8.4% |
| 2024 | -$645M | +26.9% | -$568M | $-6.12 | -16.9% | -14.9% |
| 2023 | -$882M | +56.0% | -$1.21B | $-8.45 | -35.9% | -49.1% |
| 2022 | -$2.00B | -37.5% | -$1.79B | $-19.37 | -141.5% | -126.4% |
| 2021 | -$1.46B | +10.3% | -$1.44B | $-15.21 | -123.9% | -122.3% |
| 2020 | -$1.62B | -71.3% | -$1.66B | $-19.11 | -526.1% | -536.7% |
| 2019 | -$949M | -40.8% | -$960M | $-15.86 | -221.5% | -224.2% |
| 2018 | -$674M | -623.7% | -$706M | $-12.09 | -339.9% | -356.1% |
| 2017 | -$93M | +21.9% | -$98M | $-2.21 | -39.1% | -41.3% |
| 2016 | -$119M | -108.8% | -$117M | $-3.90 | -11141.8% | -10940.2% |
Full ONC Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See ONC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ONC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ONC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonONC — Frequently Asked Questions
Quick answers to the most common questions about buying ONC stock.
Is ONC growing earnings?
ONC EPS is $4.43, with earnings growth accelerating to +637.4%. This exceeds the 5-year CAGR of N/A. TTM net income reached $513M.
What are ONC's profit margins?
BeOne Medicines Ltd. net margin is +5.4%, with operating margin at +8.4%. Margins sit within typical range for the sector.
How consistent are ONC's earnings?
ONC earnings data spans 2013-2025. The accelerating earnings trend is +637.4% YoY. Historical data enables comparison across business cycles.